News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
648,828 Results
Type
Article (49632)
Company Profile (229)
Press Release (598950)
Multimedia
Podcasts (172)
Webinars (25)
Section
Business (177981)
Career Advice (2607)
Deals (32813)
Drug Delivery (145)
Drug Development (79553)
Employer Resources (171)
FDA (16639)
Job Trends (13758)
News (315655)
Policy (32779)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2440)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (136)
Alliances (45038)
ALS (172)
Alzheimer's disease (1742)
Antibody-drug conjugate (ADC) (339)
Approvals (16810)
Artificial intelligence (535)
Autoimmune disease (159)
Automation (32)
Bankruptcy (330)
Best Places to Work (10191)
BIOSECURE Act (23)
Biosimilars (203)
Biotechnology (113)
Bladder cancer (159)
Brain cancer (57)
Breast cancer (620)
Cancer (4741)
Cardiovascular disease (415)
Career advice (2196)
Career pathing (40)
CAR-T (271)
CDC (59)
Celiac Disease (1)
Cell therapy (751)
Cervical cancer (35)
Clinical research (67994)
Collaboration (1643)
Company closure (5)
Compensation (1159)
Complete response letters (72)
COVID-19 (2792)
CRISPR (87)
C-suite (814)
Cystic fibrosis (144)
Data (6022)
Decentralized trials (2)
Denatured (49)
Depression (147)
Diabetes (494)
Diagnostics (5927)
Digital health (39)
Diversity (12)
Diversity, equity & inclusion (43)
Drug discovery (250)
Drug pricing (224)
Drug shortages (35)
Duchenne muscular dystrophy (236)
Earnings (73944)
Editorial (65)
Employer branding (20)
Employer resources (151)
Events (100044)
Executive appointments (948)
FDA (19741)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (20)
Funding (1357)
Gene editing (194)
Generative AI (47)
Gene therapy (616)
GLP-1 (1106)
Government (4355)
Grass and pollen (8)
Guidances (379)
Healthcare (16096)
HIV (59)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (286)
Immuno-oncology (58)
Indications (102)
Infectious disease (3057)
Inflammatory bowel disease (194)
Inflation Reduction Act (15)
Influenza (109)
Intellectual property (240)
Interviews (479)
IPO (15509)
IRA (58)
Job creations (3877)
Job search strategy (1813)
JPM (70)
Kidney cancer (16)
Labor market (84)
Layoffs (629)
Leadership (40)
Legal (7934)
Liver cancer (94)
Longevity (14)
Lung cancer (634)
Lymphoma (365)
Machine learning (40)
Management (59)
Manufacturing (790)
MASH (170)
Medical device (11940)
Medtech (11984)
Mergers & acquisitions (18345)
Metabolic disorders (1356)
Multiple sclerosis (162)
NASH (23)
Neurodegenerative disease (328)
Neuropsychiatric disorders (100)
Neuroscience (3012)
Neurotech (1)
NextGen: Class of 2026 (5540)
Non-profit (3458)
Now hiring (55)
Obesity (676)
Opinion (319)
Ovarian cancer (154)
Pain (202)
Pancreatic cancer (220)
Parkinson's disease (293)
Partnered (29)
Patents (490)
Patient recruitment (468)
Peanut (55)
People (54032)
Pharmaceutical (89)
Pharmacy benefit managers (33)
Phase 1 (20990)
Phase 2 (29525)
Phase 3 (22987)
Pipeline (5029)
Policy (337)
Postmarket research (2612)
Preclinical (8546)
Press Release (50)
Prostate cancer (243)
Psychedelics (56)
Radiopharmaceuticals (275)
Rare diseases (892)
Real estate (5452)
Recruiting (69)
Regulatory (25040)
Reports (44)
Research institute (2288)
Resumes & cover letters (428)
Rett syndrome (27)
RNA editing (18)
RSV (76)
Schizophrenia (157)
Series A (231)
Series B (180)
Service/supplier (14)
Sickle cell disease (101)
Special edition (27)
Spinal muscular atrophy (166)
Sponsored (46)
Startups (3377)
State (2)
Stomach cancer (20)
Supply chain (110)
Tariffs (101)
The Weekly (121)
Vaccines (1100)
Venture capital (94)
Weight loss (473)
Women's health (75)
Worklife (22)
Date
Last 7 days (584)
Last 30 days (2086)
Last 365 days (29786)
2026 (2807)
2025 (30195)
2024 (33896)
2023 (37956)
2022 (48578)
2021 (52358)
2020 (49729)
2019 (40559)
2018 (30959)
2017 (31273)
2016 (30064)
2015 (33729)
2014 (27400)
2013 (23041)
2012 (24703)
2011 (25297)
2010 (23250)
Location
Africa (801)
Alabama (71)
Alaska (7)
Arizona (249)
Arkansas (12)
Asia (40361)
Australia (6492)
California (10769)
Canada (2875)
China (1084)
Colorado (450)
Connecticut (482)
Delaware (333)
Europe (91504)
Florida (1616)
Georgia (324)
Hawaii (4)
Idaho (47)
Illinois (798)
India (64)
Indiana (459)
Iowa (22)
Japan (423)
Kansas (111)
Kentucky (36)
Louisiana (22)
Maine (76)
Maryland (1345)
Massachusetts (7884)
Michigan (272)
Minnesota (581)
Mississippi (5)
Missouri (114)
Montana (20)
Nebraska (25)
Nevada (114)
New Hampshire (65)
New Jersey (2927)
New Mexico (27)
New York (2821)
North Carolina (1436)
North Dakota (7)
Northern California (5290)
Ohio (294)
Oklahoma (17)
Oregon (38)
Pennsylvania (2105)
Puerto Rico (20)
Rhode Island (38)
South America (1175)
South Carolina (63)
South Dakota (1)
Southern California (4194)
Tennessee (157)
Texas (1610)
United States (38087)
Utah (275)
Virginia (263)
Washington D.C. (81)
Washington State (876)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
648,828 Results for "galderma pharma s a".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
January 15, 2026
·
6 min read
Press Releases
Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission
February 2, 2026
·
5 min read
Press Releases
ASDS 2025: Compelling New Data on Restylane, Sculptra and Relfydess Highlight Galderma’s Innovative Injectable Aesthetics Portfolio and Pipeline
November 17, 2025
·
13 min read
Press Releases
Galderma announces the authorization of NEMLUVIO® (nemolizumab) for atopic dermatitis and prurigo nodularis in Canada
January 12, 2026
·
11 min read
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
After Emma Walmsley steps down as GSK CEO in January, Vertex Pharma’s Reshma Kewalramani will be the sole female CEO at a top-20 pharma company. Still, there are many prominent women in pharma that could someday break through again.
September 29, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Galderma Receives U.S. FDA Approval for Restylane® Lyft™ for the Enhancement of the Chin Profile
November 5, 2025
·
9 min read
Collaboration
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy
Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with insitro, Orbital and more are building the future.
January 12, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
Galderma Announces First Patient Enrollment in Study to Assess Nemolizumab in Adults With Chronic Pruritus of Unknown Origin
December 11, 2025
·
7 min read
Government
How the UK’s ‘Credibility Challenge’ Hinders Attempts To Reverse Pharma’s Flight
Talks between pharma and successive U.K. governments have failed to deliver the market access terms that the industry wants, contributing to a pullback in investment.
October 1, 2025
·
4 min read
·
Nick Paul Taylor
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
Chief Commerical Officer Luke Miels will replace outgoing GSK CEO Emma Walmsley at the U.K. pharma next year.
September 29, 2025
·
4 min read
·
Annalee Armstrong
1 of 64,883
Next
